Giuseppe Curigliano shared a post by Vall d’Hebron Institute of Oncology on X:
“Congratulations Josep Tabernero , Enriqueta Felip, Ana Oaknin.”
Quoting Vall d’Hebron Institute of Oncology’s post:
“Congratulations!
We celebrate their achievement and applaud their impactful contributions to cancer research and clinical oncology.”
Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues. He is the Editor-in-Chief of ESMO Open, the European Society for Medical Oncology’s open-access journal.